Evidence that reduced renal medullary nitric oxide synthase activity of dahl S rats enables small elevations of arginine vasopressin to produce sustained hypertension

Hypertension

Volumn 37, Issue 2 II, 2001, Pages 524-528

  Yuan, Baozhi ^a   Cowley Jr , Allen W ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Blood pressure; Brown Norway rats; Dahl salt sensitive rats; NOS isoforms; Vasopressin

Indexed keywords

ARGIPRESSIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HYPERTENSION; INBRED STRAIN; KIDNEY MEDULLA; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SALT INTAKE;

EID: 0035090402     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.37.2.524     Document Type: Conference Paper

References (32)

1. Effect of circulating vasopressin on arterial pressure regulation in rats
2. The role of the renal medulla in volume and arterial pressure regulation
3. Acute and chronic effects of vasopressin on blood pressure, electrolytes, and fluid volumes
4. Evidence in man that urinary electrolyte loss induced by pitressin is a function of water retention
5. Chronic intravenous administration of V1 arginine vasopressin agonist results in sustained hypertension
6. Prolonged stimulation of intrarenal V1 vasopressin receptors results in sustained hypertension
7. Control of renal medullary blood flow by vasopressin V1 and V2 receptors
8. Effects of long-term vasopressin receptor stimulation on medullary blood flow and arterial pressure
9. Sensitivity of the renal medullary circulation to plasma vasopressin
10. Localization of the vasopressin V1a and V2 receptors within the renal cortical and medullary circulation
11. Nitric oxide may participate in V2-vasopressin receptor-mediated renal vasodilation
12. Nitric oxide in renal cortex and medulla. An in vivo microdialysis study
13. Arginine vasopressin-mediated stimulation of nitric oxide within the rat renal medulla
14. Nitric oxide in the renal medulla protects from vasopressin-induced hypertension
15. Mechanisms for altered endothelium-dependent vasorelaxation in isolated kidneys from experimental hypertensive rats
16. Hypertensive effects of angiotensin II in Dahl S rats is enhanced by reduced responsiveness of the renal medullary NO system
17. Genetically defined risk of salt sensitivity in an intercross of Brown Norway and Dahl S rats
18. Nitric oxide synthase activity and isoforms in rat renal vasculature
19. Renal cortical and medullary blood flow responses during water restriction: Role of vasopressin
20. Quantification of nitric oxide synthase activity in microdissected segments of the rat kidney
21. Influence of dietary sodium intake on renal medullary nitric oxide synthase
22. Increased nitric oxide synthase mRNA expression in the renal medulla of water-deprived rats
23. Vasopressin excess: Relative contribution of volume retention versus direct actions on renin secretion and sodium excretion
24. Hypertension in dogs during antidiuretic hormone and hypotonic saline infusion
25. Vasopressin in the rat with partial nephrectomy-salt hypertension
26. The role of the kidney in hypertension
27. Vascular smooth muscle nitric oxide synthase anomalies in Dahl/Rapp salt-sensitive rats
28. Absence of linkage for "endothelial" nitric oxide synthase locus to blood pressure in Dahl rats
29. Receptor subtype for vasopressin-induced release of nitric oxide from rat kidney
30. Arginine vasopressin produces renal vasodilation via V2 receptors in conscious dogs
31. A method for isolation of rat renal microvessels and mRNA localization
32. L-NAME antagonizes vasopressin V2-induced vasodilatation in dogs